 | • レポートコード：MRC2-11QY04691 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は固形腫瘍治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、ホルモン療法、免疫療法、標的療法）市場規模、用途別（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別固形腫瘍治療薬の競争状況、市場シェア ・世界の固形腫瘍治療薬市場：種類別市場規模 2015年-2020年（化学療法、ホルモン療法、免疫療法、標的療法） ・世界の固形腫瘍治療薬市場：種類別市場規模予測 2021年-2026年（化学療法、ホルモン療法、免疫療法、標的療法） ・世界の固形腫瘍治療薬市場：用途別市場規模 2015年-2020年（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他） ・世界の固形腫瘍治療薬市場：用途別市場規模予測 2021年-2026年（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他） ・北米の固形腫瘍治療薬市場分析：米国、カナダ ・ヨーロッパの固形腫瘍治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの固形腫瘍治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の固形腫瘍治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの固形腫瘍治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hoffmann-La Roche、Johnson & Johnson、Novartis、AstraZeneca、Biogen Idec、Boehringer Ingelheim、GlaxoSmithKline、Eli Lilly、Kyowa Hakko Kirin、Abbott Laboratories、Baxter International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the global solid tumor therapeutics market.
Market Analysis and Insights: Global Solid Tumor Therapeutics Market
The global Solid Tumor Therapeutics market size is projected to reach US$ 121690 million by 2026, from US$ 111440 million in 2020, at a CAGR of 8.5%% during 2021-2026.
Global Solid Tumor Therapeutics Scope and Market Size
Solid Tumor Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Hoffmann-La Roche
Johnson & Johnson
Novartis
AstraZeneca
Biogen Idec
Boehringer Ingelheim
GlaxoSmithKline
Eli Lilly
Kyowa Hakko Kirin
Abbott Laboratories
Baxter International
Market segment by Type, the product can be split into
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy
Market segment by Application, split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Solid Tumor Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Hormone Therapy
1.4.4 Immunotherapy
1.4.5 Targeted Therapy
1.5 Market by Application
1.5.1 Global Solid Tumor Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer
1.5.3 Lung Cancer
1.5.4 Colorectal Cancer
1.5.5 Prostate Cancer
1.5.6 Cervical Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Solid Tumor Therapeutics Market Perspective (2015-2026)
2.2 Global Solid Tumor Therapeutics Growth Trends by Regions
2.2.1 Solid Tumor Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Solid Tumor Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Solid Tumor Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Solid Tumor Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Solid Tumor Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Solid Tumor Therapeutics Players by Market Size
3.1.1 Global Top Solid Tumor Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Solid Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Solid Tumor Therapeutics Market Concentration Ratio
3.2.1 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Solid Tumor Therapeutics Revenue in 2019
3.3 Solid Tumor Therapeutics Key Players Head office and Area Served
3.4 Key Players Solid Tumor Therapeutics Product Solution and Service
3.5 Date of Enter into Solid Tumor Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Solid Tumor Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Solid Tumor Therapeutics Market Size by Application (2015-2020)
5.2 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Solid Tumor Therapeutics Market Size (2015-2020)
6.2 Solid Tumor Therapeutics Key Players in North America (2019-2020)
6.3 North America Solid Tumor Therapeutics Market Size by Type (2015-2020)
6.4 North America Solid Tumor Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Solid Tumor Therapeutics Market Size (2015-2020)
7.2 Solid Tumor Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Solid Tumor Therapeutics Market Size by Type (2015-2020)
7.4 Europe Solid Tumor Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Solid Tumor Therapeutics Market Size (2015-2020)
8.2 Solid Tumor Therapeutics Key Players in China (2019-2020)
8.3 China Solid Tumor Therapeutics Market Size by Type (2015-2020)
8.4 China Solid Tumor Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Solid Tumor Therapeutics Market Size (2015-2020)
9.2 Solid Tumor Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Solid Tumor Therapeutics Market Size by Type (2015-2020)
9.4 Japan Solid Tumor Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Solid Tumor Therapeutics Market Size (2015-2020)
10.2 Solid Tumor Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Solid Tumor Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Solid Tumor Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Solid Tumor Therapeutics Market Size (2015-2020)
11.2 Solid Tumor Therapeutics Key Players in India (2019-2020)
11.3 India Solid Tumor Therapeutics Market Size by Type (2015-2020)
11.4 India Solid Tumor Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Solid Tumor Therapeutics Market Size (2015-2020)
12.2 Solid Tumor Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Solid Tumor Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Solid Tumor Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Hoffmann-La Roche
13.1.1 Hoffmann-La Roche Company Details
13.1.2 Hoffmann-La Roche Business Overview
13.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Introduction
13.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2015-2020))
13.1.5 Hoffmann-La Roche Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Solid Tumor Therapeutics Introduction
13.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Solid Tumor Therapeutics Introduction
13.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Solid Tumor Therapeutics Introduction
13.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Biogen Idec
13.5.1 Biogen Idec Company Details
13.5.2 Biogen Idec Business Overview
13.5.3 Biogen Idec Solid Tumor Therapeutics Introduction
13.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.5.5 Biogen Idec Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Introduction
13.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline Solid Tumor Therapeutics Introduction
13.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview
13.8.3 Eli Lilly Solid Tumor Therapeutics Introduction
13.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 Kyowa Hakko Kirin
13.9.1 Kyowa Hakko Kirin Company Details
13.9.2 Kyowa Hakko Kirin Business Overview
13.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Introduction
13.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.9.5 Kyowa Hakko Kirin Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview
13.10.3 Abbott Laboratories Solid Tumor Therapeutics Introduction
13.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development
13.11 Baxter International
10.11.1 Baxter International Company Details
10.11.2 Baxter International Business Overview
10.11.3 Baxter International Solid Tumor Therapeutics Introduction
10.11.4 Baxter International Revenue in Solid Tumor Therapeutics Business (2015-2020)
10.11.5 Baxter International Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Solid Tumor Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Solid Tumor Therapeutics Revenue
Table 3. Ranking of Global Top Solid Tumor Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Solid Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Hormone Therapy
Table 7. Key Players of Immunotherapy
Table 8. Key Players of Targeted Therapy
Table 9. Global Solid Tumor Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Solid Tumor Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Solid Tumor Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Solid Tumor Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Solid Tumor Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Solid Tumor Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Solid Tumor Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Solid Tumor Therapeutics Players
Table 20. Global Solid Tumor Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Solid Tumor Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Therapeutics as of 2019)
Table 23. Global Solid Tumor Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Solid Tumor Therapeutics Product Solution and Service
Table 26. Date of Enter into Solid Tumor Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Solid Tumor Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Solid Tumor Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Solid Tumor Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Solid Tumor Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 36. North America Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 38. North America Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 42. Europe Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 48. China Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 50. China Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 54. Japan Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 66. India Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 68. India Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Solid Tumor Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Solid Tumor Therapeutics Market Share (2019-2020)
Table 72. Central & South America Solid Tumor Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Solid Tumor Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Solid Tumor Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Solid Tumor Therapeutics Market Share by Application (2015-2020)
Table 76. Hoffmann-La Roche Company Details
Table 77. Hoffmann-La Roche Business Overview
Table 78. Hoffmann-La Roche Product
Table 79. Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 80. Hoffmann-La Roche Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. Biogen Idec Company Details
Table 97. Biogen Idec Business Overview
Table 98. Biogen Idec Product
Table 99. Biogen Idec Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 100. Biogen Idec Recent Development
Table 101. Boehringer Ingelheim Company Details
Table 102. Boehringer Ingelheim Business Overview
Table 103. Boehringer Ingelheim Product
Table 104. Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 105. Boehringer Ingelheim Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Product
Table 109. GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 110. GlaxoSmithKline Recent Development
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Product
Table 113. Eli Lilly Company Details
Table 114. Eli Lilly Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 115. Eli Lilly Recent Development
Table 116. Kyowa Hakko Kirin Company Details
Table 117. Kyowa Hakko Kirin Business Overview
Table 118. Kyowa Hakko Kirin Product
Table 119. Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 120. Kyowa Hakko Kirin Recent Development
Table 121. Abbott Laboratories Company Details
Table 122. Abbott Laboratories Business Overview
Table 123. Abbott Laboratories Product
Table 124. Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 125. Abbott Laboratories Recent Development
Table 126. Baxter International Company Details
Table 127. Baxter International Business Overview
Table 128. Baxter International Product
Table 129. Baxter International Revenue in Solid Tumor Therapeutics Business (2015-2020) (Million US$)
Table 130. Baxter International Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Hormone Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Global Solid Tumor Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Breast Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Cervical Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Solid Tumor Therapeutics Report Years Considered
Figure 14. Global Solid Tumor Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Solid Tumor Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Solid Tumor Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Solid Tumor Therapeutics Market Share by Players in 2019
Figure 19. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Solid Tumor Therapeutics Revenue in 2019
Figure 21. North America Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Solid Tumor Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 脳腫瘍治療薬の世界市場（～2026年） A brain tumor occurs when abnormal cells form within the brain. North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics mark…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…